WO2007126889A1 - Preparation of tegaserod acetate - Google Patents
Preparation of tegaserod acetate Download PDFInfo
- Publication number
- WO2007126889A1 WO2007126889A1 PCT/US2007/007681 US2007007681W WO2007126889A1 WO 2007126889 A1 WO2007126889 A1 WO 2007126889A1 US 2007007681 W US2007007681 W US 2007007681W WO 2007126889 A1 WO2007126889 A1 WO 2007126889A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tegaserod
- acetate
- mixture
- base
- solvent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
Definitions
- the present invention relates to processes for preparing tegaserod acetate.
- Tegaserod maleate is an aminoguanidine indole 5HT4 agonist for the treatment of irritable bowel syndrome (IBS). Tegaserod maleate has the following structure:
- tegaserod as the maleate salt is a white to off-white crystalline powder and is slightly soluble in ethanol and very slightly soluble in water.
- Tegaserod maleate is disclosed in US Patent No. 5,510,353 and in its equivalent EP 0 505 322 (example 13).
- the '353 patent also discloses the preparation of tegaserod base by reacting indole-3-carbaldehyde and aminoguanid ⁇ ne in a protic solvent in the presence of inorganic or organic acid (example 2a describes the reaction in methanol and hydrochloric acid).
- a salt of tegaserod is tegaserod acetate.
- Tegaserod acetate in solid state and processes for its preparation are disclosed in PCT publication No. WO 2005/058819.
- There is a need for a one pot process suitable for industrial scale that prepares tegaserod acetate from tegaserod base intermediates without isolation of tegaserod base as an intermediate.
- the present invention provides a process for preparing tegaserod acetate, comprising reacting N-amino-N'-pentylguanidine hydroiodide ("AGP-HI”) and S-Methoxy-lH-indole-S-carbaldehyde ("MICHO”) in an aqueous reaction mixture to obtain tegaserod base; extracting the tegaserod base with a water immiscible organic solvent to obtain a mixture and combining the mixture with acetic acid to obtain tegaserod acetate.
- AGP-HI N-amino-N'-pentylguanidine hydroiodide
- MICHO S-Methoxy-lH-indole-S-carbaldehyde
- the present invention provides a process for preparing tegaserod acetate comprising reacting N-amino-N'-pentylguanidine hydroiodide ("AGP-HI”), S-Methoxy-lH-indole-S-carbaldehyde ("MICHO”) and toluene to obtain a mixture containing tegaserod base; heating the mixture and combining the mixture with acetic acid to obtain tegaserod acetate.
- AGP-HI N-amino-N'-pentylguanidine hydroiodide
- MICHO S-Methoxy-lH-indole-S-carbaldehyde
- the present invention provides a process for preparing tegaserod acetate comprising reacting N-amino-N'-pentylguanidine hydroiodide ("AGP-HI”), S-Methoxy-lH-indole-S-carbaldehyde ("MICHO”) and methyl t-butyl ether to obtain a mixture containing tegaserod base; heating the mixture and combining the mixture with acetic acid to obtain tegaserod acetate.
- AGP-HI N-amino-N'-pentylguanidine hydroiodide
- MICHO S-Methoxy-lH-indole-S-carbaldehyde
- methyl t-butyl ether methyl t-butyl ether
- the present invention provides a process for making tegaserod maleate by preparing tegaserod acetate as described above, and converting it to a tegaserod maleate.
- the term “reduced pressure” refers to a pressure below one atmosphere.
- the term “vacuum” refers to a pressure below about 50 mniHg, with about 30 mmHg or below being preferred.
- the present invention provides, a process for the preparation of tegaserod acetate.
- the process is preferably a one pot process, wherein the tegaserod base is not isolated.
- the one pot process is ideal for use on industrial scale because it avoids isolation of tegaserod base as an intermediate.
- This process comprises reacting N-amino-N'-pentylguanidine hydroiodide ("AGP-HI”) and 5-Methoxy-lH-indole-3-carbaldehyde ("MICHO”) in an aqueous reaction mixture to obtain tegaserod base; extracting the tegaserod base with a water immiscible organic solvent to obtain a mixture; and combining the mixture with acetic acid to obtain tegaserod acetate.
- AGP-HI N-amino-N'-pentylguanidine hydroiodide
- MICHO 5-Methoxy-lH-indole-3-carbaldehyde
- the reaction of AGP-HI with MICHO may be carried out under acidic or basic conditions.
- an organic or inorganic base may be used.
- the organic base is preferably a C3 to Cs alkyl amine such as trialkylamine (preferably triethylamine), or pyridine.
- the inorganic base may be an alkali/alkaline earth metal hydroxide or carbonate, preferably K 2 CO 3 , Na 2 CO 3 , NaHCO 3 , NaOH, KOH, more preferably NaOH.
- the reaction is preferably carried out at a pH range of 7 to 14, more preferably of about 9 to 14.
- the temperature range during the reaction is preferably of about 5 0 C to reflux temperature.
- the tertiary amine may also act as a solvent, thus, the reaction may be carried out in the presence of the tertiary amine in neat form, i.e. without the use of an additional solvent.
- water is added, and an organic or inorganic acid may be used.
- An organic acid such as p-toluenesulfonic acid, pyridinium p-toluenesulfonic acid, methanesulfonic acid, acetic acid or maleic acid may be used.
- an inorganic acid such as HCl, HBr, H 3 PO 4 or HaSO 4 may be used.
- the pH range during the reaction is preferably of 1 to 7, more preferably of about 3 to 4.
- the temperature range during the reaction is preferably of about 5 0 C to about reflux temperature of water.
- a base may be used to neutralize the acid used in the process or to eliminate undesirable salts.
- an aqueous solution of AGP-HI is combined with a mixture of MICHO and a solid base.
- Alkali and alkaline earth metal bases, such as potassium and sodium hydroxide may be used.
- the tegaserod formed during the reaction can be extracted into a water immiscible organic solvent.
- the water immiscible organic solvent is selected from the group consisting of: C3-C 7 esters, C4- 8 ethers and C 3 -7 ketones. More preferably, the water immiscible organic solvent is a C 3 -C 7 ester, most preferably ethyl acetate.
- ethyl acetate is mixed with the tegaserod containing reaction mixture, after which tegaserod moves to the ethyl acetate.
- the reaction mixture may be stirred to accelerate the extraction process.
- the organic phase may then be washed with an aqueous solvent such as water to remove water m ⁇ scible impurities.
- the organic phase may also be filtered to further remove impurities.
- AGP-HI and MICHO may be reacted in the presence of water without an organic solvent.
- AGP-HI and MICHO can be reacted in the presence of an organic solvent, preferably a C ⁇ -io aromatic hydrocarbon, a C 3 - 5 alkyl ester, a C 2 -S ether, C 1-S alkyl alcohol, acetonitrile and mixtures thereof.
- the AGP-HI and MICHO are reacted in a solvent selected form the group consisting of: a C ⁇ -io aromatic hydrocarbon, such as toluene; a C 3 . 5 alkyl ester such as ethyl acetate; a C 4-8 ether, such as methyl t-butyl ether; a Ci -8 alkyl alcohol such as ethanol; and acetonitrile.
- a solvent selected form the group consisting of: a C ⁇ -io aromatic hydrocarbon, such as toluene; a C 3 . 5 alkyl ester such as ethyl acetate; a C 4-8 ether, such as methyl t-butyl ether; a Ci -8 alkyl alcohol such as ethanol; and acetonitrile.
- the organic solvent is ethyl acetate.
- the ratio of ethyl acetate to MICHO is preferably about 9:1 to about 18:1 (volume/weight) Reacting AGP-HI and MICHO in the presence of an organic solvent may be followed by washing the reaction mixture with water, to reduce salt impurities. Further, the reaction mixture is combined with acetic acid.
- the mixture is heated before combining with acetic acid.
- a suitable temperature range is about 40 0 C to about 65°C, more preferably about 6O 0 C.
- the slurry resulting from combining of the mixture with acetic acid is preferably maintained at a temperature of about 40 0 C to about reflux temperature, more preferably about 60 0 C.
- the slurry is maintained so that a high yield of tegaserod acetate is obtained upon precipitation.
- the slurry is maintained for about 1 hour to about 5 hours, more preferably about 3 hours.
- the slurry is cooled to precipitate the tegaserod acetate, more preferably, to about room temperature or less, even more preferably, the slurry is cooled to about 0 0 C to about 20 0 C, and most preferably about 10 0 C.
- the tegaserod acetate is subsequently recovered by any method known in the art, such as filtration.
- the filtrate may be further washed and dried. Drying can be carried out at reduced pressure and/or elevated tempeature. In one embodiment drying is carried out at a temperature of about 3O 0 C to about 40 0 C under vacuum.
- the tegaserod acetate thus obtained is in a crystalline form, characterized by X-ray powder diffraction reflections at about: 7.3, 8.7, 10.9 and 13.5 degrees two theta ⁇ 0.2 degrees two theta.
- the present invention also provides a method for making tegaserod maleate by preparing tegaserod acetate as described above, and converting it to a tegaserod maleate.
- the conversion may be performed according to any method known in the art, such as combining with maleic acid, with or without the presence of an organic solvent.
- the obtained tegaserod maleate may be in any crystalline and/or amorphous form.
- the mixture was cooled to 10 0 C, kept under stirring at the same temperature for 2.5 hrs and then filtered under vacuum.
- the wet product was washed twice with.65 ml of ethyl acetate and dried in a vacuum oven at 45°C for 12 hours to give 84.2% of the product.
- Example 3 Preparation of TGS Acetate in MTBE 536 gr of a solution of TGS-base in MTBE is heated to 60 0 C and acetic acid (100 ml) is added, and stirred for 3 hours. The mixture is cooled to 10 0 C, kept under stirring at the same temperature for 2.5 hrs and then filtered under vacuum. The wet product is washed twice with 65 ml of toluene and dried in a vacuum oven at 45°C for 12 hours.
- Example 4 Preparation of Tegaserod maleate from Tegaserod acetate
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Indole Compounds (AREA)
Abstract
Provided are processes for preparation of tegaserod acetate and tegaserod maleate.
Description
PREPARATION OFTEGASERODACETATE
CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit of U.S. Provisional Application No.
60/786,567, filed March 27, 2006. The contents of which are incorporated herein by reference.
FIELD OF THE INVENTION The present invention relates to processes for preparing tegaserod acetate.
BACKGROUND OF THE INVENTION
Tegaserod maleate is an aminoguanidine indole 5HT4 agonist for the treatment of irritable bowel syndrome (IBS). Tegaserod maleate has the following structure:
According to the prescribing information (Physician's Desk Reference, 57th Ed., at Page 2339), tegaserod as the maleate salt is a white to off-white crystalline powder and is slightly soluble in ethanol and very slightly soluble in water.
Tegaserod maleate is disclosed in US Patent No. 5,510,353 and in its equivalent EP 0 505 322 (example 13). The '353 patent also discloses the preparation of tegaserod base by reacting indole-3-carbaldehyde and aminoguanidϊne in a protic solvent in the presence of inorganic or organic acid (example 2a describes the reaction in methanol and hydrochloric acid).
The literature (Buchheit K.H, et ah, J.Med.Chem., 1995, 38, 2331) describes a general method for the condensation of aminoguanidines with indole-3-carbaldehydes
in methanol in the presence of HCl (pH 3-4). The product obtained may be converted to its hydrochloride salt by treatment of the methanolic solution with diethyl ether/HCl followed by recrystallization from methanol/diethylether. Tegaserod base prepared according to this general method is characterized solely by a melting point of 155 0C (table 3 compound 5b). Additional Tegaserod maleate characterization was done by 1H and 13C-NMR according to the literature (Jing J. et. al., Guangdong Weiliang Yuansu Kexue, 2002, 9/2, 51).
A salt of tegaserod is tegaserod acetate. Tegaserod acetate in solid state and processes for its preparation are disclosed in PCT publication No. WO 2005/058819. There is a need for a one pot process suitable for industrial scale that prepares tegaserod acetate from tegaserod base intermediates without isolation of tegaserod base as an intermediate.
SUMMARY OF THE INVENTION In one embodiment the present invention provides a process for preparing tegaserod acetate, comprising reacting N-amino-N'-pentylguanidine hydroiodide ("AGP-HI") and S-Methoxy-lH-indole-S-carbaldehyde ("MICHO") in an aqueous reaction mixture to obtain tegaserod base; extracting the tegaserod base with a water immiscible organic solvent to obtain a mixture and combining the mixture with acetic acid to obtain tegaserod acetate.
In one embodiment the present invention provides a process for preparing tegaserod acetate comprising reacting N-amino-N'-pentylguanidine hydroiodide ("AGP-HI"), S-Methoxy-lH-indole-S-carbaldehyde ("MICHO") and toluene to obtain a mixture containing tegaserod base; heating the mixture and combining the mixture with acetic acid to obtain tegaserod acetate.
In one embodiment the present invention provides a process for preparing tegaserod acetate comprising reacting N-amino-N'-pentylguanidine hydroiodide ("AGP-HI"), S-Methoxy-lH-indole-S-carbaldehyde ("MICHO") and methyl t-butyl
ether to obtain a mixture containing tegaserod base; heating the mixture and combining the mixture with acetic acid to obtain tegaserod acetate.
In one embodiment the present invention provides a process for making tegaserod maleate by preparing tegaserod acetate as described above, and converting it to a tegaserod maleate.
DETAILED DESCRIPTION OF THE INVENTION As used herein, the term "reduced pressure" refers to a pressure below one atmosphere. As used herein, the term "vacuum" refers to a pressure below about 50 mniHg, with about 30 mmHg or below being preferred.
The present invention provides, a process for the preparation of tegaserod acetate. The process is preferably a one pot process, wherein the tegaserod base is not isolated. The one pot process is ideal for use on industrial scale because it avoids isolation of tegaserod base as an intermediate.
This process comprises reacting N-amino-N'-pentylguanidine hydroiodide ("AGP-HI") and 5-Methoxy-lH-indole-3-carbaldehyde ("MICHO") in an aqueous reaction mixture to obtain tegaserod base; extracting the tegaserod base with a water immiscible organic solvent to obtain a mixture; and combining the mixture with acetic acid to obtain tegaserod acetate.
The reaction of AGP-HI with MICHO may be carried out under acidic or basic conditions. When the reaction is carried out under aqueous basic conditions, an organic or inorganic base may be used. The organic base is preferably a C3 to Cs alkyl amine such as trialkylamine (preferably triethylamine), or pyridine. The inorganic base may be an alkali/alkaline earth metal hydroxide or carbonate, preferably K2CO3, Na2CO3, NaHCO3, NaOH, KOH, more preferably NaOH. The reaction is preferably carried out at a pH range of 7 to 14, more preferably of about 9 to 14. The temperature range during the reaction is preferably of about 50C to reflux temperature. When a tertiary amine is used, the tertiary amine may also act as a solvent, thus, the reaction may be carried out in the presence of the tertiary amine in neat form, i.e. without the use of an additional solvent.
When the reaction is carried out under acidic conditions water is added, and an organic or inorganic acid may be used. An organic acid such as p-toluenesulfonic acid, pyridinium p-toluenesulfonic acid, methanesulfonic acid, acetic acid or maleic acid may be used. In another embodiment, an inorganic acid such as HCl, HBr, H3PO4 or HaSO4 may be used. The pH range during the reaction is preferably of 1 to 7, more preferably of about 3 to 4. The temperature range during the reaction is preferably of about 50C to about reflux temperature of water. Before conversion to the acetate salt, a base may be used to neutralize the acid used in the process or to eliminate undesirable salts. In one embodiment, an aqueous solution of AGP-HI is combined with a mixture of MICHO and a solid base. Alkali and alkaline earth metal bases, such as potassium and sodium hydroxide may be used.
The tegaserod formed during the reaction can be extracted into a water immiscible organic solvent. Preferably, the water immiscible organic solvent is selected from the group consisting of: C3-C7 esters, C4-8 ethers and C3-7 ketones. More preferably, the water immiscible organic solvent is a C3-C7 ester, most preferably ethyl acetate. In one embodiment, ethyl acetate is mixed with the tegaserod containing reaction mixture, after which tegaserod moves to the ethyl acetate. The reaction mixture may be stirred to accelerate the extraction process. The organic phase may then be washed with an aqueous solvent such as water to remove water mϊscible impurities. The organic phase may also be filtered to further remove impurities.
AGP-HI and MICHO may be reacted in the presence of water without an organic solvent. Optionally, AGP-HI and MICHO can be reacted in the presence of an organic solvent, preferably a Cβ-io aromatic hydrocarbon, a C3-5 alkyl ester, a C2-S ether, C1-S alkyl alcohol, acetonitrile and mixtures thereof.
Preferably, the AGP-HI and MICHO are reacted in a solvent selected form the group consisting of: a Cβ-io aromatic hydrocarbon, such as toluene; a C3.5 alkyl ester such as ethyl acetate; a C4-8 ether, such as methyl t-butyl ether; a Ci-8 alkyl alcohol such as ethanol; and acetonitrile.
Most preferably, the organic solvent is ethyl acetate. The ratio of ethyl acetate to MICHO is preferably about 9:1 to about 18:1 (volume/weight)
Reacting AGP-HI and MICHO in the presence of an organic solvent may be followed by washing the reaction mixture with water, to reduce salt impurities. Further, the reaction mixture is combined with acetic acid.
Preferably the mixture is heated before combining with acetic acid. A suitable temperature range is about 400C to about 65°C, more preferably about 6O0C.
The slurry resulting from combining of the mixture with acetic acid is preferably maintained at a temperature of about 400C to about reflux temperature, more preferably about 600C. The slurry is maintained so that a high yield of tegaserod acetate is obtained upon precipitation. Preferably, the slurry is maintained for about 1 hour to about 5 hours, more preferably about 3 hours.
Preferably, the slurry is cooled to precipitate the tegaserod acetate, more preferably, to about room temperature or less, even more preferably, the slurry is cooled to about 00C to about 200C, and most preferably about 100C. The tegaserod acetate is subsequently recovered by any method known in the art, such as filtration. The filtrate may be further washed and dried. Drying can be carried out at reduced pressure and/or elevated tempeature. In one embodiment drying is carried out at a temperature of about 3O0C to about 400C under vacuum.
Preferably, the tegaserod acetate thus obtained is in a crystalline form, characterized by X-ray powder diffraction reflections at about: 7.3, 8.7, 10.9 and 13.5 degrees two theta ± 0.2 degrees two theta.
The present invention also provides a method for making tegaserod maleate by preparing tegaserod acetate as described above, and converting it to a tegaserod maleate.
The conversion may be performed according to any method known in the art, such as combining with maleic acid, with or without the presence of an organic solvent.
The obtained tegaserod maleate may be in any crystalline and/or amorphous form.
EXAMPLES
Instruments:
X-Ray powder diffraction data were obtained using by method known in the art using 5 a SCINTAG powder X-Ray diffractometer model X'TRA equipped with a solid state detector. Copper radiation of 1.5418 A was used. A round aluminum sample holder with zero background was used. AU peak positions are within kθ.2 degrees two theta.
Example 1 — Preparation of Tegaserod acetate
Preparation of Tegaserod base
To a mixture of AGP-HI (434.4 g) in 1158 mL of water was added 5-MICHO (180 g) followed by NaOH (130 g, 47%) and stirred 400C. After 60 hours, 2140 mL of ethyl acetate was added and the mixture was stirred for an additional 1.5 hours. After phase separation the organic phase was washed with water (670 ml), and filtrated under vacuum to give a clear solution of TGS Base. Preparation of Tegaserod acetate 536 gr of a solution of TGS-base (obtained in Example 1) was heated to 600C and acetic acid (100 ml) was added, and the reaction mixture stirred at the same temperature for an additional three hours. The mixture was cooled to 100C, kept under stirring at the same temperature for 2.5 hrs and then filtered under vacuum. The wet product was washed twice with.65 ml of ethyl acetate and dried in a vacuum oven at 45°C for 12 hours to give 84.2% of the product.
Example 2 — Preparation of TGS Acetate in toluene
536 gr of a solution of TGS-base in toluene is heated to 600C and acetic acid (100 ml) is added, and stirred for 3 hours. The mixture is cooled to 100C, kept under stirring at the same temperature for 2.5 hrs and then filtered under vacuum. The wet product is washed twice with 65 ml of toluene and dried in a vacuum oven at 45°C for 12 hours.
Example 3 — Preparation of TGS Acetate in MTBE 536 gr of a solution of TGS-base in MTBE is heated to 600C and acetic acid (100 ml) is added, and stirred for 3 hours. The mixture is cooled to 100C, kept under stirring at the same temperature for 2.5 hrs and then filtered under vacuum. The wet product is washed twice with 65 ml of toluene and dried in a vacuum oven at 45°C for 12 hours.
Example 4: Preparation of Tegaserod maleate from Tegaserod acetate
Maleic acid is added to a mixture of tegaserod acetate in a solvent (or without) at room temperature. The mixture is stirred till the conversion to tegaserod maleate and filtered and washed with a solvent. The mixture may be dried on vacuum oven at 45°C for 15 hours.
Having thus described the invention with reference to particular preferred embodiments and illustrative examples, those in the art may appreciate modifications to the invention as described and illustrated that do not depart from the spirit and scope of the invention as disclosed in the specification. The Examples are set forth to aid in understanding the invention but are not intended to, and should not be construed to, limit its scope in any way. The examples do not include detailed descriptions of conventional methods. Such methods are well known to those of ordinary skill in the art and are described in numerous publications.
Claims
1. A process for preparing tegaserod acetate, comprising reacting N-amino-N'- pentylguanidine hydroiodide ("AGP-HI") and 5-Methoxy-lH-indole-3- carbaldehyde ("MICHO") in an aqueous reaction mixture to obtain tegaserod base; extracting the tegaserod base with a water immiscible organic solvent to obtain a mixture and combining the mixture with acetic acid to obtain tegaserod acetate.
2. The process of claim 1, wherein the tegaserod base is not isolated.
3. The process any one of claims 1 or 2, wherein the reaction between AGP-HI and MICHO is carried out under acidic or basic pH.
4. The process of claim 3, wherein the pH is higher than about 7.
5. The process of claim 4, wherein the base is a C3 to Cs alkyl amine.
6. The process of claim 5, wherein the base is triethylamine.
7. The process of claim 6, wherein the tritethylamine is a neat reagent.
8. The process of claim 3, wherein the base is an alkali/alkaline earth metal hydroxide or carbonate.
9. The process of claim 3, wherein the base is K2CO3, Na2CO3, NaHCO3, NaOH, KOH or pyridine.
10. The process of claim 9, wherein the base is NaOH.
11. The process of any of the preceding claims, wherein the temperature range during the reaction between AGP-HI and MICHO is of about 50C to about reflux temperature.
12. The process of claim 3 or 11, wherein the pH range is about less than 7.
13. The process of claim 12, wherein the acid is p-toluensulfonic acid, pyridinium p- toluenesulfonic acid, methanesulfonic acid, acetic acid or maleic acid.
14. The process of claim 12, wherein the acid is HCl, HBr, H3PO4 or H2SO4.
15. The process of any one of claims 1-3 or 11, wherein an aqueous solution of AGP- HI is combined with a mixture of MICHO and a solid base.
16. The process of any of the preceding claims, wherein the water immiscible organic solvent is selected from the group consisting of: C3-C7 esters, C3-8 ethers, and C3-7 ketones.
17. The process of any of the preceding claims, wherein the water immiscible organic solvent is a C3-C7 ester.
18. The process of claim 17, wherein the solvent is ethyl acetate.
19. The process of claim 18, wherein the ethyl acetate is mixed with the tegaserod containing reaction mixture, after which tegaserod moves to the ethyl acetate.
20. The process of any of the preceding claims, wherein the AGP-HI and MICHO are reacted in the presence of an organic solvent.
21. The process of claim 20, wherein the solvent is selected from the group consisitng ofC6-io aromatic hydrocarbons, C3-5 alkyl ester, C2-8 ether, Ci-s alkyl alcohols, acetonitrile and mixtures thereof
22. The process of claim 21, wherein the solvent is a C6-Io aromatic hydrocarbon.
23. The process of claim 21, wherein the solvent is toluene.
24. The process of claim 21, wherein the solvent is a C3.5 alkyl ester.
25. The process of claim 21, wherein the solvent is ethyl acetate.
26. The process of claim 25, wherein the ratio of ethyl acetate to MICHO is about 9:1 to about 18:1 (volume/weight).
27. The process of claim 21, wherein the solvent is a C2-8 ether.
28. The process of claim 21, wherein the solvent is methyl t-butyl ether.
29. The process of claim 21, wherein the solvent is a Ci-g alkyl alcohol.
30. The process of claim 21, wherein the solvent is ethanol.
31. The process of claim 1, wherein the aqueous reaction comprises water.
32. The process of claim 21, wherein the solvent is acetonitrile.
33. The process of any of the preceding claims, wherein the mixture is heated before addition of acetic acid.
34. The process of claim 33, wherein the temperature range is about 400C to about 65°C.
35. The process of any of the preceding claims, wherein the combining of the mixture with acetic acid results in a slurry which is maintained at a temperature of about 400C to about reflux temperature.
36. The process of claim 35, wherein the slurry is maintained for about 1 hour to about 5 hours.
37. The process of claim 35, wherein the slurry is cooled to precipitate the tegaserod acetate.
38. The process of any of the preceding claims, wherein the slurry is cooled to about room temperature or less.
39. The process of claim 39, wherein the slurry is cooled to about 00C to about 200C.
40. The process of any of the preceding claims, further comprising drying at a temperature of about 3O0C to about 4O0C.
41. The process of any of the preceding claims, wherein the tegaserod acetate recovered is in a crystalline form, characterized by X-ray powder diffraction reflections at about: 7.3, 8.7, 10.9 and 13.5 degrees two theta ± 0.2 degrees two theta.
42. A process for preparing tegaserod acetate comprising reacting N-amino-N'- pentylguanidine hydroiodide ("AGP-HI") and 5-Methoxy-lH-indole-3- carbaldehyde ("MICHO") in an aqueous reaction mixture to obtain tegaserod base; extracting the tegaserod base with ethyl acetate; separating the ethyl acetate from the aqueous reaction mixture; filtering the ethyl acetate to obtain a solution; heating the solution and combining the solution with acetic acid to obtain tegaserod acetate.
43. A process for preparing tegaserod acetate comprising reacting N-amino-N'- pentylguanidine hydroiodide ("AGP-HI"), S-Methoxy-lH-indoIe-3-carbaldehyde ("MICHO") and toluene to obtain a mixture containing tegaserod base; heating the mixture and combining the mixture with acetic acid to obtain tegaserod acetate.
44. A process for preparing tegaserod acetate comprising reacting N-amino-N'- pentylguanidine hydroiodide ("AGP-HI"), 5-Methoxy-lH-indole-3-carbaldehyde ("MICHO") and methyl t-butyl ether to obtain a mixture containing tegaserod base; heating the mixture and combining the mixture with acetic acid to obtain
• tegaserod acetate.
45. A method for preparing tegaserod maleate comprising preparing tegaserod acetate according to any of the preceding claims, and converting the tegaserod acetate to tegaserod maleate.
46. A one pot process for preparing tegaserod acetate.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78656706P | 2006-03-27 | 2006-03-27 | |
US60/786,567 | 2006-03-27 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/772,110 Continuation-In-Part US8092007B2 (en) | 2006-01-13 | 2010-04-30 | Eyewear frames with magnetic lens attachments |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007126889A1 true WO2007126889A1 (en) | 2007-11-08 |
Family
ID=38371032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/007681 WO2007126889A1 (en) | 2006-03-27 | 2007-03-27 | Preparation of tegaserod acetate |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007126889A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005058819A2 (en) * | 2003-12-16 | 2005-06-30 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of tegaserod base and salts thereof |
WO2005105740A2 (en) * | 2004-04-26 | 2005-11-10 | Teva Pharmaceutical Industries Ltd. | Preparation of tegaserod and tegaserod maleate |
WO2006045120A2 (en) * | 2004-10-19 | 2006-04-27 | Teva Pharmaceutical Industries Ltd. | Purification of tegaserod maleate |
WO2006096802A1 (en) * | 2005-03-08 | 2006-09-14 | Teva Pharmaceutical Industries Ltd. | Amorphous tegaserod maleate |
-
2007
- 2007-03-27 WO PCT/US2007/007681 patent/WO2007126889A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005058819A2 (en) * | 2003-12-16 | 2005-06-30 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of tegaserod base and salts thereof |
WO2005105740A2 (en) * | 2004-04-26 | 2005-11-10 | Teva Pharmaceutical Industries Ltd. | Preparation of tegaserod and tegaserod maleate |
WO2006045120A2 (en) * | 2004-10-19 | 2006-04-27 | Teva Pharmaceutical Industries Ltd. | Purification of tegaserod maleate |
WO2006096802A1 (en) * | 2005-03-08 | 2006-09-14 | Teva Pharmaceutical Industries Ltd. | Amorphous tegaserod maleate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7799916B2 (en) | Process for the preparation of 5-(4-[4-(5-cyano-3-indolyl)butyl]-1-piperazinyl)benzofuran-2-carboxamide | |
WO2006116953A1 (en) | A method for the preparation of tegaserod and slected salts thereof | |
JP2006502121A (en) | Preparation of 1H-imidazo- [4,5-c] quinolin-4-amine via 1H-imidazo [4,5-c] quinoline-4-phthalimide intermediate | |
CA2884197A1 (en) | Methods for the preparation of indacaterol and pharmaceutically acceptable salts thereof | |
KR20170029506A (en) | Process for the preparation of 4-alkoxy-3-hydroxypicolinic acids | |
US7696356B2 (en) | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom | |
RU2744976C1 (en) | Method for producing 1-(4-methanesulfonyl-2-trifluoromethyl-benzyl)-2-methyl-1h-pyrrolo[2,3-b]pyridin-3-yl-acetic acid | |
WO2007126889A1 (en) | Preparation of tegaserod acetate | |
US9321712B2 (en) | Process for the preparation of ospemifene | |
KR20080031910A (en) | Process for the preparation of 1-[cyano(4-hydroxyphenyl)methyl]cyclohexanol compounds | |
EP2928472B1 (en) | Process for making reverse transcriptase inhibitors | |
JP2010254692A (en) | Method for purifying paliperidone | |
CN101405267A (en) | Process for preparing l-halo-2,7-naphthyridinyl derivatives | |
US20070225507A1 (en) | Process for preparing a crystalline form of Tegaserod maleate | |
JP4984676B2 (en) | Preparation of aniline having benzyloxy group | |
WO2005120498A2 (en) | Method for synthesis of lonidamine and related indazole derivatives | |
EP2865662A1 (en) | Process for the preparation of a thrombopoietin agonist | |
JP2005097149A (en) | Solvate of [3-[(2r)-[[(2r)-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1h-indol-7-yloxy]acetic acid | |
JP4323874B2 (en) | Novel alkyl vinyl ether substituted trinuclear polyphenols | |
EP0976731B1 (en) | Process for producing 5-methylindolines | |
KR20140127996A (en) | Novel polymorphs of lenalidomide and preparation method thereof | |
JP2020059693A (en) | Method for preparing apronal and intermediate thereof | |
KR20050026095A (en) | Method for producing highly pure hydroxy indolyl glyoxylic acid amides | |
WO2007099082A1 (en) | Novel method for the preparation of stavudine polymorphic form i and form ii | |
JP2006056832A (en) | Method for producing and purifying 4-hydroxyquinolines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07754234 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07754234 Country of ref document: EP Kind code of ref document: A1 |